Events in our system are self-managed.  Group and event managers are encouraged to review privacy and security settings, and adjust them if needed.  If you need assistance please contact Indico Support - contact Help at bottom of page.

Apr 1 – 5, 2019
Fairmont Château Laurier Hotel
UTC timezone

High-Purity Actinium-225 Production from Radium-226 using a Superconducting Electron Linac

Not scheduled
Fairmont Château Laurier Hotel

Fairmont Château Laurier Hotel


Dr Terry Grimm (Niowave, Inc.)


Niowave is operating a closed-loop cycle to domestically produce high-purity Ac-225 and other alpha emitters from Ra-226 using a superconducting electron linear accelerator. The commercial-scale system will produce 10 Ci per week of Ac-225 from a nitrate-based solution of Ra-226. The electron beam impinges on a photon converter to irradiate the Ra-226, inducing a photon-neutron reaction to Ra-225, which decays to Ac-225. Ac 225 is eluted continuously from the target vessel then centrifugal contactors are used to harvest and purify Ac 225 through a separation cascade. Unlike other production methods, including proton linacs (spallation of Th-232) and proton cyclotrons (Ra-226 bombardment), Niowave’s method does not generate any Ac-227 contamination in the Ac-225 product. Niowave’s superconducting linacs can handle higher production output (>500 Ci per year using a 20 MeV, 210 kW beam) than any other method. Demonstration-scale production of 10 mCi batches of Ac-225 at Niowave’s HQ has begun and will be complete in April 2019. Niowave is in a unique position to quickly take the lead in alpha-emitters for cancer therapy because they have expertise in superconducting electron linacs and an NRC materials license to possess and irradiate Ra-226 while capturing gaseous radioisotopes and progeny. This presentation will focus on Niowave’s scale up plans to full production including radium acquisition, NRC and FDA licensing strategies, and a path to profitability.
Email Address
Presentation Type Contributed Oral

Primary author

Dr Terry Grimm (Niowave, Inc.)


Amanda Grimm (Niowave, Inc.) Mike Zamiara (Niowave, Inc.) Dr William Peters (Niowave, Inc.)

Presentation materials

There are no materials yet.